Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth A Ross

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Cannabis and Cannabinoid Research|October 17, 2022
Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of PsychosisCatharine A Mielnik, Chun Kit Li, Amy J Ramsey, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 2, 2008
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activationChristopher M Henstridge, Nariman A B Balenga, Lesley A Ford, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 7, 2005
Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptorsDouglas McHugh, R Shannon McMaster, Roger G Pertwee, et al.
British Journal of Pharmacology|October 6, 2005
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonistAdèle Thomas, Lesley A Stevenson, Kerrie N Wease, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 13, 2010
Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levelsSuthat Liangpunsakul, Margaret S Sozio, Eric Shin, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamideRuth A Ross, Susan J Craib, Lesley A Stevenson, et al.
The Journal of Biological Chemistry|October 27, 2011
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoidsSharon Anavi-Goffer, Gemma Baillie, Andrew J Irving, et al.
Alzheimer Disease and Associated Disorders|May 13, 2026
Cognitive and Neuroanatomical Effects of Fatty Acid Amide Hydrolase Polymorphism rs324420 in Aging and Alzheimer DiseaseDaniel K Mori-Fegan, Yuen Yan Wong, Shiropa Noor, et al.
Bioresearch Open Access|December 4, 2015
Molecular Profiling of Multiplexed Gene Markers to Assess Viability of Ex Vivo Human Colon Explant CulturesJanice E Drew, Andrew J Farquharson, Hollie Vase, et al.
Hepatology Communications|April 13, 2019
Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in HumansZhihong Yang, Praveen Kusumanchi, Ruth A Ross, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cannabis and Cannabinoid Research|October 17, 2022
Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of PsychosisCatharine A Mielnik, Chun Kit Li, Amy J Ramsey, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 2, 2008
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activationChristopher M Henstridge, Nariman A B Balenga, Lesley A Ford, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 7, 2005
Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptorsDouglas McHugh, R Shannon McMaster, Roger G Pertwee, et al.
British Journal of Pharmacology|October 6, 2005
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonistAdèle Thomas, Lesley A Stevenson, Kerrie N Wease, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 13, 2010
Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levelsSuthat Liangpunsakul, Margaret S Sozio, Eric Shin, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamideRuth A Ross, Susan J Craib, Lesley A Stevenson, et al.
The Journal of Biological Chemistry|October 27, 2011
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoidsSharon Anavi-Goffer, Gemma Baillie, Andrew J Irving, et al.
Alzheimer Disease and Associated Disorders|May 13, 2026
Cognitive and Neuroanatomical Effects of Fatty Acid Amide Hydrolase Polymorphism rs324420 in Aging and Alzheimer DiseaseDaniel K Mori-Fegan, Yuen Yan Wong, Shiropa Noor, et al.
Bioresearch Open Access|December 4, 2015
Molecular Profiling of Multiplexed Gene Markers to Assess Viability of Ex Vivo Human Colon Explant CulturesJanice E Drew, Andrew J Farquharson, Hollie Vase, et al.
Hepatology Communications|April 13, 2019
Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in HumansZhihong Yang, Praveen Kusumanchi, Ruth A Ross, et al.
Pageof 7